The Cancer

Don't Miss

How Caregivers Can Assist Liked Ones With Lung Most cancers Really feel in Management

Chris Draft mentioned sufferers with lung most cancers and their caregivers can regain management after analysis by displaying up, staying knowledgeable and leaning into advocacy,...

Household Begins AYA Most cancers Basis After Lymphoma Prognosis

Elaine Riozzi Bodine and her daughter Alayna turned a life-altering analysis right into a mission to help different adolescents and younger adults with most cancers....

Childhood Most cancers Survivors Face Lengthy-Time period Meningioma Danger

Researchers at UT Southwestern Medical Heart led a research revealed in JAMA Community Open which discovered that particular chemotherapies are related to an elevated long-term...

Vital Information

Facts

Latest Articles

Perioperative Opdivo Extends Occasion-Free Survival in Lung Most cancers

Sufferers with resectable (surgically unremovable) non-small cell lung most cancers (NSCLC) present process remedy with perioperative Opdivo (nivolumab) demonstrated prolonged event-free survival (EFS;...

Longer Time Till Recurrence Related With Higher Melanoma Outcomes

Receiving postsurgical therapy with immunotherapy might lengthen the time till relapse.Amongst sufferers with superior melanoma, an extended time till illness recurrence was related...

Most cancers Makes Me Take a look at Life In a different way

Linda Cohen is a survivor of small lymphocytic lymphoma and was identified in 2009. Atone for all of Linda's blogs right here!In the...

Gleevec Interruption in GIST Related to Resistance, Recurrence, Dying

Stopping Gleevec remedy for superior gastrointestinal stromal tumors (GIST) can result in sooner resistance and improve the chance of the illness getting worse...

Herceptin, Perjeta Routine Might Be Efficient With out Chemo in Breast Most cancers

Remedy with Herceptin (trastuzumab) and Perjeta (pertuzumab) with endocrine remedy however with out chemotherapy has been proven to doubtlessly be an efficient therapy...

Hot Topics